Search Results - "Chanda, Monica"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Metabolic engineering generates a transgene-free safety switch for cell therapy by Wiebking, Volker, Patterson, James O., Martin, Renata, Chanda, Monica K., Lee, Ciaran M., Srifa, Waracharee, Bao, Gang, Porteus, Matthew H.

    Published in Nature biotechnology (01-12-2020)
    “…Safeguard mechanisms can ameliorate the potential risks associated with cell therapies but currently rely on the introduction of transgenes. This limits their…”
    Get full text
    Journal Article
  2. 2

    The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites by Libring, Sarah, Shinde, Aparna, Chanda, Monica K, Nuru, Maryam, George, Heather, Saleh, Aya M, Abdullah, Ammara, Kinzer-Ursem, Tamara L, Calve, Sarah, Wendt, Michael K, Solorio, Luis

    Published in Cancers (17-05-2020)
    “…In breast cancer (BC), tissue stiffening via fibronectin (FN) and collagen accumulation is associated with advanced disease progression at both the primary…”
    Get full text
    Journal Article
  3. 3

    Combined analysis of T cell activation and T cell-mediated cytotoxicity by imaging cytometry by Chanda, Monica K., Shudde, Claire E., Piper, Taylor L., Zheng, Yating, Courtney, Adam H.

    Published in Journal of immunological methods (01-07-2022)
    “…Immunotherapies for the treatment of cancer have spurred the development of new drugs that seek to harness the ability of T cells to recognize and kill…”
    Get full text
    Journal Article
  4. 4

    Fibronectin-Expressing Mesenchymal Tumor Cells Promote Breast Cancer Metastasis by Jun, Brian H., Guo, Tianqi, Libring, Sarah, Chanda, Monica K., Paez, Juan Sebastian, Shinde, Aparna, Wendt, Michael K., Vlachos, Pavlos P., Solorio, Luis

    Published in Cancers (08-09-2020)
    “…Tumor metastasis is connected to epithelial-mesenchymal heterogeneity (EMH) and the extracellular matrix (ECM) within the tumor microenvironment…”
    Get full text
    Journal Article
  5. 5

    Advances in the discovery and development of melanoma drug therapies by Chanda, Monica, Cohen, Mark S

    Published in Expert opinion on drug discovery (02-11-2021)
    “…Therapeutic strategies for melanoma have evolved significantly over the last decade shifting from cytotoxic chemotherapies like dacarbazine to targeted…”
    Get more information
    Journal Article
  6. 6

    Uncovering the role of STAT5 in CD8+ T cell fate by Chanda, Monica Kasturi, Gu, Zehui, Piper, Taylor L, Shudde, Claire E, Courtney, Adam H

    Published in The Journal of immunology (1950) (01-05-2023)
    “…Abstract Long-term protection against infection and disease requires long-lived memory CD8+ T cells. The development of these memory CD8+ T cells requires a…”
    Get full text
    Journal Article
  7. 7

    Combined analysis of T cell activation and T cell-mediated cytotoxicity by imaging cytometry by Chanda, Monica Kasturi, Shudde, Claire E, Piper, Taylor L, Zheng, Yating, Courtney, Adam H

    Published in The Journal of immunology (1950) (01-05-2022)
    “…Abstract Immunotherapies have transformed the treatment of cancer through the development of drugs that allow T cells to recognize and kill malignant cells…”
    Get full text
    Journal Article
  8. 8

    An engineered viral protein rewires signaling pathways to overcome T cell suppression by Zheng, Yating, Gu, Zehui, Shudde, Claire, Piper, Taylor, Wang, Xinyu, Aleck, Grace, Zhou, Jiajia, Chanda, Monica, Trinch, Lilliana, Zou, Weiping, Courtney, Adam

    Published in The Journal of immunology (1950) (01-05-2024)
    “…Abstract Cancer can evade destruction by depriving T cells of cytokines, such as IL-2, that cause JAK-STAT signaling required for T cell functionality. We…”
    Get full text
    Journal Article
  9. 9

    A novel C-terminal Hsp90 inhibitor KU758 synergizes efficacy in combination with BRAF or MEK inhibitors and targets drug-resistant pathways in BRAF-mutant melanomas by Sanchez, Jackee N., Subramanian, Chitra, Chanda, Monica, Shanguan, Gary, Zhang, Nina, Wang, Ton, Timmermann, Barbara N., Blagg, Brian S.J., Cohen, Mark S.

    Published in Melanoma research (01-06-2021)
    “…Melanoma remains the most aggressive and fatal form of skin cancer, despite several FDA-approved targeted chemotherapies and immunotherapies for use in…”
    Get full text
    Journal Article
  10. 10

    The Role Of CD90 in Breast Cancer Tumor Progression by Chanda, Monica Kasturi

    Published 01-01-2020
    “…Breast cancer is the most common cancer among women, with effective treatments if the disease stays local. However, if the tumor metastasizes, patient outcomes…”
    Get full text
    Dissertation
  11. 11

    Correlation of Structural and Macroscopic Properties of Starches with Their Tabletability Using the SM(2) Approach by Dave, Vivek S, Chanda, Monica, Sayles, Matt, Popielarczyk, Michael, Boyce, Heather, Bompelliwar, Sai Krishna, Bates, Simon, Morris, Ken R, Haware, Rahul V

    Published in Journal of pharmaceutical sciences (01-11-2015)
    “…The effects of PURE-DENT® and SPRESS® starch properties on their compression behavior was characterized using "SM(2) " approach (structural properties,…”
    Get more information
    Journal Article